Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | hydroxycarboxylic acid receptor 2 | Starlite/ChEMBL | References |
Homo sapiens | hydroxycarboxylic acid receptor 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | G-protein coupled receptor, putative | hydroxycarboxylic acid receptor 2 | 363 aa | 294 aa | 20.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.1263 | 0.1904 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0046 | 0.6636 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | unspecified product | 0.002 | 0.1263 | 0.1904 |
Leishmania major | DNA polymerase eta, putative | 0.0046 | 0.6636 | 0.615 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.002 | 0.1263 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0032 | 0.3829 | 0.2937 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0062 | 1 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 0.1263 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Echinococcus granulosus | dna polymerase eta | 0.0046 | 0.6636 | 0.615 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0046 | 0.6636 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0046 | 0.6636 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0046 | 0.6636 | 0.615 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.6636 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.002 | 0.1263 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0032 | 0.3829 | 0.4775 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.1263 | 0.1904 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 1 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0046 | 0.6636 | 0.615 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.002 | 0.1263 | 0.5 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0062 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CL (ADMET) | = 47 ml/min.kg | Plasma clearance in C57BL/6 mouse at 1 mg/kg, iv and 2 mg/kg, po | ChEMBL. | 19307116 |
F (ADMET) | = 57 % | Bioavailability in C57BL/6 mouse at 1 mg/kg, iv and 2 mg/kg, po | ChEMBL. | 19307116 |
IC50 (binding) | = 0.08 uM | Displacement of [3H]nicotinic acid from mouse GPR109a receptor | ChEMBL. | 19307116 |
IC50 (binding) | = 0.14 uM | Displacement of [3H]nicotinic acid from human GPR109a receptor | ChEMBL. | 19307116 |
T1/2 (ADMET) | = 1.8 hr | Plasma half life in C57BL/6 mouse at 1 mg/kg, iv and 2 mg/kg, po | ChEMBL. | 19307116 |
Vdss (ADMET) | = 1.79 L/Kg | Volume of distribution at steady state in C57BL/6 mouse at 1 mg/kg, iv and 2 mg/kg, po | ChEMBL. | 19307116 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.